Status of progess to fix sustainable growth rate physician formula, other rheumatology-related issues facing Congress
The ACR Testifies before Congress on Patient Access
The ACR’s Government Affairs Committee chair Will Harvey, MD, brings lawmakers’ attention to Patients’ Access to Treatments Act, problem of specialty drug tiers, excessive cost sharing for patients
Rheumatology Advocacy Starts at Home
The ACR expands advocacy efforts to impact state legislatures, local organizations
The ACR’s Advocacy Leadership Conference Brings Volunteers to Washington, D.C.
Concerns over rheumatology patient care, research funding, Medicare discussed with Congressional representatives
Teaching Rheumatology in Haiti
Rheumatologist Ronald J. Anderson, MD, describes volunteer experience with medical residents, teaching rheumatology
How Rheumatologists Can Connect with Congressional Lawmakers during August Recess
Tips on scheduling in-office meetings in legislators’ home districts and which issues to discuss
Practicing Rheumatology in Dubai
Rheumatologist Humeira Badsha, MD, describes caring for rheumatology patients in the United Arab Emirates, launching the Emirates Arthritis Foundation
Update on Healthcare Reform in 2014 under the Affordable Care Act
The American College of Rheumatology continues to monitor healthcare system changes under the ACA; educate rheumatologists, rheumatology health professionals
ARHP Member Donald R. Miller, PharmD, Named to FDA Arthritis Advocacy Committee
Dr. Miller, professor, chair of pharmacy practice at North Dakota State University, to evaluate new drugs seeking first-time FDA approval
ACR Board of Directors Tackles Slate of Business at Annual Meeting
Board welcomes 233 new and returning candidates, lends support to lupus classification criteria in partnership with EULAR, approves update of ACR policy statements and position statements at February meeting in Napa, Calif.
- « Previous Page
- 1
- …
- 15
- 16
- 17
- 18
- 19
- …
- 30
- Next Page »